Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mount Nittany Medical Center
mi
from
State College, PA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Chester County Hospital
mi
from
West Chester, PA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Chester County Hospital
mi
from
West Chester, PA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Instituto Nacional de Enfermedades Neoplasicas
mi
from
Lima,
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Instituto Nacional de Enfermedades Neoplasicas
mi
from
Lima,
Click here to add this to my saved trials
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
A Phase 1b/2a Study of ABT-888 in Combination With Bendamustine +/- Rituximab in Lymphoma, Multiple Myeloma and Solid Tumors
Status: Enrolling
Updated:  10/14/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
A Phase 1b/2a Study of ABT-888 in Combination With Bendamustine +/- Rituximab in Lymphoma, Multiple Myeloma and Solid Tumors
Status: Enrolling
Updated: 10/14/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated:  10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated: 10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated:  10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Effect of HIV Infection and HAART on Bone Homeostasis
Status: Enrolling
Updated: 10/15/2015
Grady Infectious Diseases Program Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Diablo Clinical Research Inc
mi
from
Walnut creek, CA
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Clincal Research of Atlanta
mi
from
Stockbridge, GA
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Clincal Research of Atlanta
mi
from
Stockbridge, GA
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Advanced Clinical Research
mi
from
Boise, ID
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Advanced Clinical Research
mi
from
Boise, ID
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Johnson County Clin-Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
QPS Bio-Kinetic
mi
from
Springfield, MO
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
QPS Bio-Kinetic
mi
from
Springfield, MO
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Coastal Carolina Research
mi
from
Mt. Pleasant, SC
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Coastal Carolina Research
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Research Across America
mi
from
Dallas, TX
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated:  10/15/2015
Jean Brown Research
mi
from
Salt Lake City, UT
RSV F Dose-Ranging Study in Women
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615
mi
from
Birmingham, AL
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Premier Health Research 9317 Firestone Blvd.
mi
from
Downey, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Premier Health Research 9317 Firestone Blvd.
mi
from
Downey, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624
mi
from
Oakland, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624
mi
from
Oakland, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Center for Clinical Trials LLC, 16660 Paramount Blvd, Suite 301
mi
from
Paramount, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Center for Clinical Trials LLC, 16660 Paramount Blvd, Suite 301
mi
from
Paramount, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308
mi
from
Paramount, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308
mi
from
Paramount, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kaiser Permanente Pleasanton 7601 Stoneridge Drive, Second Floor
mi
from
Pleasanton, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kaiser Permanente Pleasanton 7601 Stoneridge Drive, Second Floor
mi
from
Pleasanton, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kaiser Permanente San Francisco 2200 O'Farrell St., Sixth Floor
mi
from
San Francisco, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kaiser Permanente San Francisco 2200 O'Farrell St., Sixth Floor
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kaiser Permanente Santa Clara 710 Lawrence Expressway, Pediatric Clinic Department
mi
from
Santa Clara, CA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kaiser Permanente Santa Clara 710 Lawrence Expressway, Pediatric Clinic Department
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Children's Memorial Hospital 2300 Children's Plaza, Box 155
mi
from
Chicago, IL
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Children's Memorial Hospital 2300 Children's Plaza, Box 155
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kentucky Pediatric/Adult Research 201 South Fifth Street, Suite 102
mi
from
Bardstown, KY
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kentucky Pediatric/Adult Research 201 South Fifth Street, Suite 102
mi
from
Bardstown, KY
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
28 Annapolis Pediatrics, 200 Forbes Street, Suite 200
mi
from
Annapolis, MD
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
28 Annapolis Pediatrics, 200 Forbes Street, Suite 200
mi
from
Annapolis, MD
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Senders Pediatrics 2054 South Green Road
mi
from
Cleveland, OH
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Senders Pediatrics 2054 South Green Road
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Children's Health Care 2501 West 12th Street
mi
from
Erie, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Children's Health Care 2501 West 12th Street
mi
from
Erie, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Pennridge Pediatric Associates 270 Main Street
mi
from
Harleyville, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Pennridge Pediatric Associates 270 Main Street
mi
from
Harleyville, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Kid's Way Pediatrics 3068 Innovation Way
mi
from
Hermitage, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Kid's Way Pediatrics 3068 Innovation Way
mi
from
Hermitage, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Site 35, Pennridge Pediatric Associates, 711 Lawn Avenue
mi
from
Sellersville, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Site 35, Pennridge Pediatric Associates, 711 Lawn Avenue
mi
from
Sellersville, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Pediatric Medical Associates 1077 Rydal Road
mi
from
Suite 300 Rydal, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Pediatric Medical Associates 1077 Rydal Road
mi
from
Suite 300 Rydal, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
Pediatric Medical Associates 160 West Germantown Pike
mi
from
Suite D2 East Norriton, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
Pediatric Medical Associates 160 West Germantown Pike
mi
from
Suite D2 East Norriton, PA
Click here to add this to my saved trials
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated:  10/19/2015
PEAK Research 2859 Washington Rd., Ste. 412B
mi
from
Upper St. Clair, PA
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
A Phase IIIb, Open-Label, Controlled, Multi-Center Study to Evaluate the Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine
Status: Enrolling
Updated: 10/19/2015
PEAK Research 2859 Washington Rd., Ste. 412B
mi
from
Upper St. Clair, PA
Click here to add this to my saved trials
A Pilot Dose Ranging Study of Spinosad Creme Rinse
Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study
Status: Enrolling
Updated:  10/19/2015
Hill Top Research
mi
from
West Palm Beach, FL
A Pilot Dose Ranging Study of Spinosad Creme Rinse
Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study
Status: Enrolling
Updated: 10/19/2015
Hill Top Research
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Oncology Patients With Neutropenic Fever
Status: Enrolling
Updated:  10/20/2015
OHSU Knight Cancer Institute
mi
from
Portland, OR
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
Phase II Open Label Pilot Trial of Empiric Daptomycin Treatment for Oncology Patients With Neutropenic Fever
Status: Enrolling
Updated: 10/20/2015
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials